BASEL, SWITZERLAND — February 25, 2002 — Four out of five adults with the itching skin disease, atopic eczema, experienced improvement of their condition with a new treatment based on the non-steroid cream, Elidel® (pimecrolimus), according to study results released today. The study, presented at the annual meeting of the American Academy of Dermatology in New Orleans, USA, also showed that seven out of 10 adults were considered by their doctors to have been successfully treated with the cream-based regimen, and the itching associated with eczema began to ease on average within two days of starting Elidel.
The results build on the efficacy seen with younger patients. In previous studies, itching was relieved within one week in up to 70 percent of babies aged three to 23 months treated with Elidel. Seven out of 10 babies, and 61 percent of children aged two to 17 years, had their eczema under control over six months without any steroids, by using Elidel at the first signs of disease – such as redness and swelling – or itching. …
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!